BMY vs BIIB
Bristol Myers Squibb vs Biogen — AI-powered side-by-side comparison
| Metric | BMY | BIIB |
|---|---|---|
| AI Score | 56 | 61 |
| Price | $65.30 | $202.89 |
| P/E Ratio | 14.39× | 35.73× |
| ROE | 0.4% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.7% |
| Debt / Equity | 1.93× | 0.44× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 79.6 | 48.3 |
| Beta | 0.235 | 0.158 |
| Expected Upside | +1.4% | +1.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
BIIB Full Analysis